FLOX-0-ZOLE TAB is a synergistic antimicrobial therapy that brings together the fluoroquinolone antibiotic Ofloxacin and the nitroimidazole antiprotozoal Metronidazole. The combination is highly effective in treating mixed infections, particularly those involving anaerobic bacteria and protozoa — often seen in gastrointestinal disorders, gynecological conditions, and post-operative infections.
This formulation is developed and manufactured by BluepillExpress, an internationally accredited third-party manufacturer and merchant exporter. The company’s robust production infrastructure ensures stringent adherence to international standards of quality, efficacy, and safety, with regulatory support for seamless global distribution.
Therapeutic Indications
Amoebic and bacterial dysentery
Giardiasis
Pelvic Inflammatory Disease (PID)
Bacterial vaginosis
Abdominal and post-surgical infections
Infective diarrhea and traveler’s diarrhea
Dental infections
Periodontal abscesses
Mixed infections of the gastrointestinal tract, reproductive organs, and respiratory system
Mechanism of Action
Ofloxacin: A fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death.
Metronidazole: A nitroimidazole class antibiotic that gets activated in anaerobic conditions and disrupts DNA synthesis in protozoa and anaerobic bacteria.
Together, they deliver comprehensive antimicrobial action that is effective against both aerobic and anaerobic pathogens, as well as protozoal organisms.
Description provided by bluepill express.
FIEO Registered
Export Ready
